Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection

SH Safiabadi Tali, JJ LeBlanc, Z Sadiq… - Clinical microbiology …, 2021 - Am Soc Microbiol
SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

Neurological issues in children with COVID-19

JE Lin, A Asfour, TB Sewell, B Hooe, P Pryce… - Neuroscience …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) usually leads to a mild infectious disease
course in children, but serious complications may occur in conjunction with both acute …

[PDF][PDF] Living guidance for clinical management of COVID-19: living guidance, 23 November 2021

World Health Organization - 2021 - apps.who.int
This guideline is based on the above strategic priorities, and is intended for clinicians
involved in the care of patients with suspected or confirmed COVID-19. It is not meant to …

[PDF][PDF] COVID-19 clinical management: living guidance, 25 January 2021

(‎ 2021 World Health Organization - 2021 - apps.who.int
The guidance in this document is based on the above strategic priorities, and is intended for
clinicians involved in the care of patients with suspected or confirmed COVID-19. It is not …

Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome

KL LaRovere, BJ Riggs, TY Poussaint… - JAMA …, 2021 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult
patients. The spectrum of neurologic involvement in children and adolescents is unclear …

[PDF][PDF] Clinical management of COVID-19: living guideline, 13 January 2023

World Health Organization - 2023 - apps.who.int
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS-
CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at …

Multisystem inflammatory syndrome in children (MIS-C)

JM Patel - Current allergy and asthma reports, 2022 - Springer
Abstract Purpose of Review The novel coronavirus disease 2019 (COVID-19) is caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has developed into a …

The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: A systematic review

S Kunal, P Ish, P Sakthivel, N Malhotra, K Gupta - Heart & Lung, 2022 - Elsevier
Background The exact prevalence of Multisystem Inflammatory Syndrome in Adults (MIS-A)
is largely unknown. Vague and multiple definitions and treatment options often add to the …

Safety, immunogenicity, and efficacy of COVID-19 vaccines in children and adolescents: A systematic review

M Lv, X Luo, Q Shen, R Lei, X Liu, E Liu, Q Li, Y Chen - Vaccines, 2021 - mdpi.com
Aim: To identify the safety, immunogenicity, and protective efficacy of COVID-19 vaccines in
children and adolescents. Methods: We conducted a systematic review of published studies …

Emerging evidence on multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection: a systematic review with meta-analysis

M Sood, S Sharma, I Sood, K Sharma… - SN comprehensive clinical …, 2021 - Springer
With the increased spread of severe acute respiratory syndrome coronavirus 2 infection,
more patients with multisystem inflammatory syndrome in children (MIS-C) are being …